Not a good buy right now for an impatient entry: price is below key support and momentum is still deteriorating (bearish MACD expansion).
While fundamentals are improving YoY and the pattern-based model suggests a decent 1-month upside skew, the near-term technical setup favors more downside/whipsaw before a cleaner bounce.
Prefer to wait for either (1) a rebound back above S1 (64.57) with stabilization, or (2) a flush toward S2 (61.21) followed by a clear reversal; at the current level, risk/reward is not attractive for immediate entry.
Intellectia signals are absent today (no AI Stock Picker, no SwingMax), so there is no proprietary “must-buy-now” trigger supporting an aggressive entry.
Technical Analysis
Trend/momentum: MACD histogram is -0.911 and negatively expanding → bearish momentum is strengthening, not bottoming.
RSI: RSI_6 at 21.45 indicates an oversold/washed-out condition (despite the label saying “neutral”), which can produce bounces, but oversold alone is not a buy signal when MACD is still worsening.
Moving averages: converging MAs suggest indecision/transition, but current momentum favors bears.
Key levels: Current ~63.45 is below S1 (64.569), increasing odds of a test of S2 (61.205). Pivot resistance is far above at ~70.014; a recovery above S1 then pivot would be more constructive.
Market backdrop: S&P 500 is down ~0.98% today, which is a mild headwind for near-term risk appetite.
Financial momentum: 2026/Q3 revenue +22.95% YoY; net income +11.03% YoY; EPS +11.11% YoY.
Pattern-based forward view provided: similar candlestick patterns imply a positive 1-month skew (not a guarantee), with +11.73% as the indicated next-month move.
No notable hedge fund or insider selling pressure flagged recently (both neutral).
Neutral/Negative Catalysts
with bearish MACD expansion increases probability of continuation toward S2 (~61.21).
Net income: 3,384,642 (+11.03% YoY) → profitable with continued growth.
EPS: 0.70 (+11.11% YoY) → earnings growth intact.
Gross margin: 78.59% (-6.72% YoY) → profitability per dollar of sales weakened; worth monitoring if it persists.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided in the dataset, so there is no confirmed recent Wall Street trend to cite.
With limited Street visibility here, the practical pro view would center on strong YoY revenue/EPS growth; the con view would focus on margin compression and a currently weak technical setup below support.
Politicians/congress: No recent congress trading data available in the last 90 days (no confirmed influential-figure buying/selling signal from the provided data).
Wall Street analysts forecast NVEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVEC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast NVEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVEC is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
